Different expression of Bcl-2 protein in gastric adenomas and carcinomas

Pathology International

Volumn 46, Issue 4, 1996, Pages 274-280

  Uesugi, Hidenaga ^a   Saegusa, Makoto ^a   Takano, Yasuo ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bcl 2; gastric adenoma; gastric carcinoma; Ki 67; p53

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN P53;

ADENOMA; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; STOMACH ADENOMA; STOMACH CARCINOMA;

EID: 0029922574     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03610.x     Document Type: Article

References (29)

1. Watanabe H, Jass JR, Sobin LH. Histological typing of oesophageal and gastric tumors. In: International Histological Classification of Tumors, 2nd edn. World Health Organisation, Geneva, 1990; 19-20.
2. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen, A. Precancerous conditions and epithelial dysplasia in the stomach. J. Clin. Pathol. 1980; 33: 711-721.
3. Correa P. Precursors of gastric and esophageal cancer. Cancer 1982; 50: 2554-2565.
4. Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer 1982; 50: 2496-2503.
5. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal tumor development. N. Engl. J. Med. 1988; 319: 525-532.
6. Baker SJ, Preisinger AC, Jessup JM et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990; 50: 7717-7722.
7. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097-1099.
8. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229-240.
9. Chandler D, El-Naggar AK, Brisbay S, Redline RW, McDonnell TJ. Apoptosis and expression of the Bcl-2 protooncogene in the fetal and adult human kidney: Evidence for the contribution of Bcl-2 expression to renal carcinogenesis. Hum. Pathol. 1994; 25: 789-796.
10. Pezzella F, Turley H, Kuzu I et al. Bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med. 1993; 329: 690-694.
11. McDannell TJ, Troncoso P, Brisbay SM et al. Expression of the protooncogene Bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992; 52: 6940-6944.
12. Bronner MP, Culin C, Reed JC, Furth EE. The Bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol. 1995; 146: 20-26.
13. Ito H, Hata J, Yokozaki H, Nakatani H, Oda N, Tahara E. Tubular adenoma of the human stomach. An immunohistochemical analysis of gut hormones, serotonin, carcinoembryonic antigen, secretory component, and lysozyme. Cancer 1986; 58: 2264-2272.
14. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol. Jpn. 1982; 32: 329-347.
15. Iida F, Murata F, Nagata T. Histochemical studies of mucosubstances in metaplastic epithelium of the stomach, with special reference to the development of intestinal metaplasia. Histochemistry 1978; 56: 229-237.
16. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995; 55: 237-241.
17. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol. 1994; 145: 1191-1198.
18. Sugano H, Nakamura K, Takagi K. An atypical epithelium of the stomach. A clinico-pathological entity. Gann Monograph. Cancer Res. 1971; 11: 257-269.
19. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995; 75: 2209-2213.
20. Novack DV, Korsmeyer SJ. Bcl-2 protein expression during murine development. Am. J. Pathol. 1994; 145: 61-73.
21. Saraga E-P, Gardiol D, Costa J. Gastric dysplasia. A histological follow-up study. Am. J. Surg. Pathol. 1987; 11: 788-796.
22. Kolodziejczyk P, Yao T, Oya M et al. Long term follow-up study of patients with gastric adenomas with malignant transformation. Cancer 1994; 74: 2896-2907.
23. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. Down-regulation of Bcl-2 by p53 in breast cancer cell. Cancer Res. 1994; 54: 2095-2097.
24. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res. 1994; 54: 3131-3135.
25. Pilotti S, Collini P, Rilke F, Cattoretti G, Bo RD, Pierotti MA. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J. Pathol. 1994; 172: 337-342.
26. Saegusa M, Takano Y, Okaysu I. Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal megaplasia. J. Cancer Res. Clin. Oncol. 1995; 121: 357-363.
27. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80 293-299.
28. Shiao Y-H, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am. J. Pathol. 1994 144: 511-517.
29. Tohdo H, Yokozaki H, Haruma K, Kajiyama G, Tahara E. p53 gene mutations in gastric adenomas. Virchows Arch. B. Cell Pathol. 1993; 63: 191-195.